TIFFANY BENNETT: Open Payments
NPI 1134785769 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 6 payments from 5 companies in 2025. Trend: 2023 $990 · 2024 $638 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Astellas Pharma US Inc | 1 | $30 |
| Amgen Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: CAPLYTA, Wegovy, Veozah, KRYSTEXXA.
Industry payments across MS — which companies pay providers there.
